title: Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?
authors.affiliation: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy. breccia@bce.uniroma1.it
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Voso
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine